Filter
100
Featured
Recommendations
13
New Publications
1
Language
Document type
Situation Updates
25
Fact sheets
16
Resource Platforms
11
Guidelines
11
Studies & Reports
8
Online Courses
7
Strategic & Response Plan
6
No document type
5
Infographics
4
Videos
4
Training Material
2
Manuals
1
Countries / Regions
Africa
7
Congo, Democratic Republic of
3
Germany
3
Nigeria
2
Global
2
West and Central Africa
1
Western and Central Europe
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
33
Key Resources
7
Women & Child Health
2
Capacity Building
1
Public Health
1
Countries
1
Ressource Platform
On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union
...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr
...
The Global Strategic Preparedness and Response Plan (SPRP) for mpox, covering the six-month period from September 2024 to February 2025, provides a framework for public health preparedness and response to the mpox emergency. The current draft, subject to Member State input, outlines the urgent actio
...
WHO Director-General Dr Tedros Adhanom Ghebreyesus has determined that the upsurge of mpox in the Democratic Republic of the Congo (DRC) and a growing number of countries in Africa constitutes a public health emergency of international concern (PHEIC) under the International Health Regulations (2005
...
The monkeypox virus (MPXV) clade I epidemic that has been affecting the Democratic Republic of the Congo
(DRC) since November 2023 has recently spread to several other African countries including Burundi, Rwanda,
Uganda and Kenya. The size of these outbreaks could be larger than reported due to un
...
Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV)
recommended
Orientations provisoires
Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People
...
WHO needs US$ 87.4 million over 6 months, from September 2024 to February 2025, to work with countries, partners and other stakeholders to stop and contain the current outbreak of mpox.
Download (419.34 KB)
On 14 August 2024, the Director-General of the World Health Organization (WHO) determined that the resurgence of Mpox in the Democratic Republic of Congo (DRC) and a growing number of countries in Africa constitutes a Public Health Emergency of International Concern (PHEIC). Te
...
Bulletin 11 August 2024
Le Directeur général de l’OMS, le Dr Tedros Adhanom Ghebreyesus, a estimé que la recrudescence de variole simienne (mpox) en République démocratique du Congo (RDC) et dans un nombre croissant de pays d’Afrique constituait une urgence de santé publique de portée internationale (USPPI) au t
...
Given the circulation of the variant of clade I of mpox virus (MPXV) in the African Region, which is associated in the African Region with sustained transmission and the occurrence of cases in a wider range of age groups, including children, the Pan American Health Organization/World Health Organiza
...
Situation Update
En décembre 2022, la République démocratique du Congo a déclaré une flambée nationale de variole simienne. Un système de gestion des incidents est en place depuis février 2023, compte tenu du nombre croissant de cas signalés. Depuis septembre 2023, l’épidémie de variole simienne continu
...
i. A person who is a contact of a probable or confirmed mpox case in the 21 days before the onset of signs or symptoms, and who presents with any of the following: acute onset of fever (>38.5°C), headache, myalgia (muscle pain/body aches), back pain, profound weakness or fatigue.
OR
ii. A per
...
mise à jour de la situation
Fact Sheet
